Johnson & Johnson (NYSE:JNJ), a worldwide leader in multiple myeloma therapies, today announced that the U.S. Food and Drug Administration (FDA) approved TECVAYLI® (teclistamab-cqyv) plus DARZALEX ...

Herpes simplex virus partially liquifies the tightly packed, gel-like interior of human cell nuclei to copy itself faster, a new study shows.

ARDT Investors with Losses Encouraged to Contact Hagens BermanSAN FRANCISCO, March 5, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens ...

FRMI Investors with Losses Encouraged to Contact Hagens Berman Before Mar. 6th DeadlineSAN FRANCISCO, March 5, 2026 ...